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a  b  s  t  r  a  c  t
Aim:  The  aim  of  this  study  is to  evaluate  the  effects  of Zinc  Oxide  nanoparticles  on  dose  enhancement
factor  using  PRESAGE  dosimeter  and  Monte  Carlo  simulation.
Background:  High  Z materials  absorb  X-ray  remarkably.  Among  Nano-science,  Zinc  Oxide  nanoparticles
are  interesting  semiconductors,  producing  reactive  oxygen  species  when  irradiated  by photons.  There-
fore, it  seems  that  dose  enhancement  originating  by incorporating  ZnO  NPs  in  irradiated  volume  would
increase  the  therapeutic  ratio.
Materials  and  methods:  Initially,  the  PRESAGE  dosimeter  was  fabricated  and calibrated.  Then  Zinc  Oxide
nanoparticles  with  an  average  particle  size  of  about  40 nm  were  synthesized.  At  next  step,  various  concen-
trations  of the  nanoparticles  were  incorporated  into  the  PRESAGE  composition  and  irradiated  in  radiation
fields.  Then,  the  mentioned  processes  were  simulated.
Results: Practical  measurements  revealed  that  by  incorporating  500,  1000  and  3000  g  ml−1 ZnO  NPs
into  PRESAGE  the  dose  enhancement  factor  of 1.36, 1.39,  1.44  for 1  × 1  cm 2 field  size,  1.39,  1.41,  1.46  for
2  × 2 cm 2 and  1.40, 1.45  and  1.50 for  3  ×  3 cm 2 could  be  found,  respectively.  Simulation  results  showed
2that  in  the  mentioned  condition,  the  dose  enhancement  factor  of 1.05,  1.08,  1.10  for  1  ×  1 cm field  size,
1.06,  1.09,  1.10  for 2 × 2 cm 2 and  1.08,  1.11 and 1.13  for 3 ×  3  cm 2 could  be  derived,  respectively.
Conclusion:  The  results  of this  study  showed  that  dose  enhancement  increases  by increasing  concentra-
tion  of  Zinc  Oxide  nanoparticles.  Many  reasons  such  as  photoelectric,  pair  production  effects  and  even
Compton  scattering  can cause  dose  enhancement  for megavoltage  beams.
©  2020  Greater  Poland  Cancer  Centre.  Published  by  Elsevier  B.V.  All  rights  reserved.. Background
Advanced and complex radiation therapy delivery techniques
re currently used with the goal of escalating tumor dose and min-
mizing normal tissues complications. Among these progressive
ethods, the use of nanotechnology offers some exciting possi-
ilities including the opportunity of destroying cancerous tumors
ith minimal damage to healthy tissues1–6
Among Nano-science, Zinc Oxide nanoparticles (ZnO NPs) are
nteresting wide band gap semiconductors (3.37 eV), producing
eactive oxygen species (ROS) and oxygen free radicals when irradi-
ted by photons.7–9 It has been demonstrated that high Z materials
bsorb X-ray remarkably. Therefore, it seems that dose enhance-
ent originating by incorporating ZnO NPs in irradiated volume
ould increase the therapeutic ratio significantly.10–12
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507-1367/© 2020 Greater Poland Cancer Centre. Published by Elsevier B.V. All rights resDose enhancement factor is more important in small radiation
fields where the lack of lateral electronic equilibrium condition
leads to employing higher numbers of monitor units (MU) to deliver
a certain amount of absorbed dose.12
It seems that using the recently introduced water equivalent
radiochromic PRESAGE dosimeter would be a proper method to
evaluate the effects of ZnO NPs. This type of dosimeter is formu-
lated with a free radical initiator, leuco dye and polyurethane and
their optical properties are changed in proportion to the absorbed
dose.13
Another useful method for evaluating dose enhancement is
using Monte Carlo (MC) simulation. Several MC  studies have been
done to explain events responsible for the biological outcomes.14–15
2. AimThe aim of this study is to determine the dose enhancement
factor of ZnO NPs by use of the PRESAGE dosimeter and Monte
Carlo simulation in small radiation fields.
erved.
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Table 1
Percentage chemical composition of PRESAGE.
Components Polyurethane LMG  CCl4




































ig. 1. Set up of irradiation: Various slab phantoms are used to prepare electronic
quilibrium condition. The center of PRESAGE filled cuvettes are placed at depth of
.5  cm.
. Materials and methods
This study consists of two sections: experimental measure-
ents and Monte Carlo simulations.
.1. Experimental phase
.1.1. PRESAGE dosimetry
In order to perform the experimental phase of the study, the
ater equivalent PRESAGE dosimeter was fabricated. The proce-
ure consists of mixing CCl4 (Merck, Keinlworth, United States) and
eucomalachite green (LMG) (Sigma Aldrich, St Louis, MO,  United
tates). Then a polyurethane resin (Crystal Clear 2006, Smooth-On,
aston, PA, USA) which was supplied in two parts (Part A and Part
) were mixed together by ratio of 100 to 90 to afford optically
lear polyurethane resins that form the matrix of the PRESAGE
osimeter. The solutions prepared were combined together and
horoughly mixed. Then the prepared mixture was poured into poly
pectrophotometer cuvettes and the filled cuvettes were kept in a
ressure pot (60 psi) for 5 days to minimize outgassing.13,15
Table 1 shows the percentage composition of PRESAGE. By using
ayneord formula and considering the elemental compositions of
RESAGE, the effective atomic number of the fabricated dosimeter
ould be 7.8.16
The maximum pre-irradiation absorptions of cuvettes were then
etermined using UV-Vis spectrophotometer (Varian, Palo Alto,
alifornia, USA). The next process was calibration of PRESAGE
gainst the ionization chamber (Farmer chamber, 0.6 cc, PTW,
reiburg, Germany) to deliver definite steps of absorbed dose.
uvettes were placed in a solid water phantom made by Plexi-
las and irradiated in a 15 × 15cm2 field to deliver the absorbed
oses including 0, 0.5, 1, 2, 4, 6, 8, 10, 12, 14, 16, 18, 20 Gy at depth
f 2.5 cm,  irradiated by 6 MV  photon beams produced by Varian
linac 2100 C linear accelerator (Varian, Palo Alto, California, USA).
arious slab phantoms were used to prepare the electronic equilib-
ium condition (Fig. 1). For each dose step, three cuvettes were used.
ll cuvettes were kept in a dark and cold environment to prevent
ny accidental absorption change and 48 h after irradiation, again
y using UV-Vis spectrophotometer, the maximum absorption ofnd Radiotherapy 25 (2020) 515–520
each cuvette was  obtained. Finally, a calibration curve, which is the
variations of optical density changes against absorbed doses, was
plotted.
3.1.2. Nanoparticle synthesization
At the next step, ZnO NPs were prepared and incorporated in
to the composition of the PRESAGE and the irradiation processes
were repeated. Nanoparticles were prepared by chemical precip-
itation route using zinc acetate, sodium hydroxide and absolute
ethanol. Zinc acetate dehydrate (0.2195 g) was dissolved in 20 mL
of absolute ethanol and stirred with a magnetic stirrer at room tem-
perature, to be mixed thoroughly. Then the solution of NaOH (0.08 g
NaOH in 20 mL  of absolute ethanol) was  added drop-wise into the
solution of zinc acetate under constant magnetic stirring for 1 h.
After that, 0.015 mmol  of oleic acid was  added into the solution.
The white powder was obtained after stirring this solution at room
temperature for another 1 h. The prepared dispersion was centrifu-
gally filtered and washed several times with ethanol and distilled
water, then dried in an oven at 50 ◦C for 4 h.17
3.1.3. Characterization of NPs
The properties of the prepared nanoparticles were found with
the help of a scanning electron microscope (SEM) and X-ray diffrac-
tion (XRD).
3.1.4. Dosimetry with NPs
At the next stage, various concentrations of ZnO NPs (500, 1000,
3000 g ml-1) were incorporated into the composition of PRESAGE
and the irradiation processes were repeated in three small fields
(1 × 1, 2 × 2 and 3 × 3 cm2).
Ultimately, by comparing the results of optical density changes
in the presence and absence of NPs, dose enhancement factor was
determined.
3.2. Monte Carlo simulation
MCNP5 Monte Carlo code was  used to simulate the related
geometry. At the onset of this part, by using information of Varian
oncology system, the head of Varian Clinac 2100C linear accelera-
tor, producing 6 MV  photon beams, consisting of a target, primary
collimator, flattening filter, ion chamber, secondary collimator, and
a water phantom with dimensions of 30 × 30 × 30 cm3 at distance
of 100 cm from the target were simulated. The number of particles
was set to be 2 × 109 and the *f8 tally was used to calculate energy
deposition of electrons, photons and neutrons at specific points.
The extracted parameters of this simulation were percentage
depth dose (PDD) and beam profile of 6 MV  photon beams in a
3 × 3 cm2 field size.
In order to validate the simulation, a relative dosimetry was
done in a water phantom and mentioned field size. Then, the
obtained PDD and beam profile were compared with those of sim-
ulation. Since there is a high dose gradient in small radiation fields,
in order to create a better spatial resolution of the measured data,
the smallest effective volume of the ion chamber (0.015 cc), known
as pinpoint (PTW, Freiburg, Germany), was  used.
The next step was the simulation of ZnO NPs and PRESAGE
dosimeter. PRESAGE compositions, which are shown in Table 1,
were simulated with dimension of 1 × 1×3.5 cm3, located in the
water phantom.
For NPs simulation, initially the required concentration of
nanoparticles was specified. Then, the number of nanoparticles in a
certain concentration was  calculated. This procedure is as follows:
If 500 g ml−1 of ZnO NPs was  incorporated into a volume of
3.5 cm3 water equivalent PRESAGE composition, the volume of
applied NPs would be 3.1 × 10-4 cm3.


































Fig. 3. XRD pattern of prepared ZnO NPs.
Fig. 4. SEM photo of ZnO NPs.Fig. 2. Schematic of simulated geometry and NPs distributions.





here v and r represent the volume and radius of the sphere,
espectively. By using scanning electron microscopy (SEM), the
verage diameter of nanoparticles was determined to be about
0 nm.  Therefore, the volume of each nanoparticle would be
.3 × 10−17 cm3. By dividing the total volume by that of each
anoparticle, the number of NPs was established as 9 × 1012.
By repeating lattices in such a way to locate one NP in each cell,
he uniform distribution of NPs was simulated.
In order to get this pattern, three levels of lattice definitions
ere used. The sizes of these levels were in orders of millimeter,
icrometer and nanometer, respectively. Millimeter and microme-
er cubic cells were filled by PRESAGE substance and the nanometer
ells contained nanoparticles. In order to reduce runtime for fur-
her process, phase space file was used. This option of the MCNP5
ode is one of the variance reduction methods that makes it possi-
le to simulate a radiation source in an input and hypothetically see
he influence of that source in another input file. Since low energy
hoton beams and electrons have significant influence on DEF, no
nergy cut off was used and by using the *f8 tally, the deposited
nergy was acquired across the central axis and at depth of maxi-
um  dose (2.5 cm)  in terms of MeV  and, then, DEF was obtained as
he ratio of deposited energy in the presence of NPs to that of a no
Ps condition. Fig. 2 depicts the schematic of simulated geometry
nd NPs distributions.




The XRD pattern of synthesized ZnO nanoparticles is shown in
ig. 3. X-ray diffraction study confirmed that the synthesized mate-
ials were ZnO and all the diffraction peaks agreed with the reported
CPDS data. By using EM3200 Scanning Electron Microscopy (KYKY,
ntario, USA), the size distribution of Zinc Oxide NPs was deter-
ined. As can be seen in Fig. 4, the mean size of NPs is about
0 nm.Fig. 5. The absorption spectrum of PRESAGE with and without NPs over visible
wavelengths.
Fig. 5 represents the absorption spectrum of PRESAGE with and
without NPs over visible wavelength. As can be seen, the maximum
absorption of samples occurred at about 632 nm.
Fig. 6 depicts the calibration curve of PRESAGE over various dose
levels. This calibration is determined at a wavelength of 632 nm
which was  the maximum absorption wavelength of PRESAGE.
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Fig. 6. PRESAGE calibration curve.
Table 2
DEF measured by PRESAGE.
DEF Concentration of NPs Field size (cm2)






























Max  dose point
(cm)
1.6 1.8
Beam Profile Max  difference at
flat region (%)
0.9%






DEF calculated bsy Monte Carlo simulation.
DEF Concentration of NPs Field size (cm2)
1.051.081.10  500 g/mL1000 g/mL3000 g/mL 1*1
F
c
1.391.411.46 500 g/mL1000 g/mL3000 g/mL 2*2
1.401.451.50  500 g/mL1000 g/mL3000 g/mL 3*3
Dose enhancement factor (DEF) is defined as the ratio of changes
n optical density with NPs to the optical density changes without
Ps.18
Since PRESAGE exhibits a linear behavior against various dose
evels (Fig. 6), by comparing the optical density changes at a par-
icular dose step with and without NPs, DEF could be determined.
The DEF, as defined above, was then acquired for different com-
ositions of PRESAGE in the small studied fields (Table 2).
.2. Monte Carlo simulation
Fig. 7 shows the percentage depth dose and beam profile of
he 3 × 3 cm2 field irradiated by 6 MV  photon beams, obtained by
CNP5 code and pinpoint ion chamber as the simulation validation
arameters.
Table 3 shows the comparison of acquired data by simulation
nd ion chamber. A good agreement (around 2% deviation) is found
etween experimental measurement and simulation data. There-
ore, the results of simulation are reliable.
Table 4 shows the DEF obtained by simulation. Fig. 8 delineates
he comparison of data obtained by experimental measurements
ig. 7. Monte Carlo validation parameters. a: Percentage depth dose obtained by MCNP5
hamber.1.061.091.10  500 g/mL1000 g/mL3000 g/mL 2*2
1.081.111.13 500 g/mL1000 g/mL3000 g/mL 3*3
and Monte Carlo simulation for various concentrations of applied
NPs in three studied field sizes. This figure implies that the results
obtained by simulation are not consistent with experimental data.
Moreover, a small increscent in DEF is shown by increasing the
concentrations of NPs and field sizes.
Since in small radiation fields, lateral electronic equilibrium
does not exist, higher numbers of monitor units (MU) are needed
to deliver a certain amount of absorbed dose.19
Higher amounts of MU  lead to excessive time of treatment and,
consequently, the probability of random errors and patient move-
ments during treatment will rise. Therefore, finding a solution to
overcome such a problem is essential. The results of this study
showed that a good value of DEF could be derived by incorporating
ZnO NPs.
Experimental measurements and simulation data (Fig. 8) show
that dose enhancement grows by increasing the concentration of
NPs. In fact, by increasing the concentration of NPs, the number
of NPs in a certain volume of PRESAGE would increase and, there-
fore, the probability of photon interaction with NPs would increase
 and pinpoint ion chamber. b: Beam profile obtained by MCNP5 and pinpoint ion
N. Banaee / Reports of Practical Oncology a


















be considered as a proper method for simulating NPs distribution,ize,  b: 2 × 2 field size, c:3 × 3 field size.
nd, hence, the DEF would grow and consequently the needed MU
o deliver each step of absorbed dose would reduce. But it should
e noted that the correlation between increasing dose enhance-
ent and concentration of NPs is not linear. As shown in Fig. 8,
wo fold increase in concentration of NPs leads to a little growth of
EF. The explanation for this matter is probably that the increase
n concentration of NPs shields the radiosensitive components of
he dosimeter (LMG) interacting with X-rays. In other words, radi-
tion interacts with the NPs and produces secondary electrons and
ree radicals or ions. These products should interact directly with
he LMG converting it to its oxidized form. However, increasing the
oncentration of NPS could show a shielding property, preventing
he electrons hit the LMG.20
As Tables 2 and 4 illustrate, DEF increases by increasing field size.
hat reveals that by decreasing the size of radiation field, lateral
catter disequilibrium becomes higher which causes less output
actor for such fields compared to bigger ones.nd Radiotherapy 25 (2020) 515–520 519
In order to reach logic DEF, homogeneous dispersion of NPs in
the irradiated volume is needed. Regarding the heavy weight of ZnO
NPs compared to PRESAGE, some portion of this substance may  be
settled in PRESAGE. Whereas, in the simulation section, the distri-
bution of NPs in PRESAGE structure is completely homogeneous. In
order to create a similar condition of simulation and experimental
measurements and prevent the settling of NPs, as explained in NPs
synthesization section, Oleic acid was added to the composition of
the needed materials. This substance makes the NPs dispersible in
organic solvents and to some extent reduces their aggregation.17
The other important parameter in calculating and measuring
DEF is the method of selecting sampling points. In other words, the
energy deposition in the Monte Carlo section is calculated in the
introduced cells with certain dimensions and also positions. Read-
out by UV-Vis spectrophotometer is done on the whole thickness of
the cuvettes. Therefore, the data extracting points in Monte Carlo
simulation and UV-Vis spectrophotometer do not quite match. It is
also notable that the size distribution of NPs may have an impor-
tant role on DEF. As shown in Fig. 3, in reality, sizes of NPs are not
definite and have a spectrum. However, in the Monte Carlo section,
the mean size of NPs was  used to do the simulation.
Furthermore, as explained in methodology, in order to take
into consideration the effects of the low energy electrons on dose
enhancement factor, no energy cut off was used. By not specify-
ing a cut off energy in the input file, MCNP5 uses a minimum cut
off energy of 1 keV for both electrons and photons.21 In this way, a
large number of Auger electrons whose energy is below the cut off
would be ignored. However, in reality, these electrons and photons
still leak out of the NP and contribute to the dose outside of the NP.
Therefore, it seems that MCNP5 is not the best tool to compute the
energy deposition of such low energy electrons.
Therefore, the differences in results of the DEF obtained by
experimental measurements and simulation could be the conse-
quences of various patterns of NPs’ distribution, different style of
data extracting points, not considering the size distribution of NPs
in simulation and also the effects of Auger electrons which are
ignored in simulation.
Although DEF is usually attributed by Orthovoltage photon
beams, where photoelectric effect is dominant, the results of this
study showed that DEF can be achieved by megavoltage photon
beams as well. In this situation, DEF may  be the results of low energy
photons in the continuous X-ray spectrum, attenuated photons,
probably the pair production effect and even Compton scattering.
By incorporating ZnO NPs into PRESAGE structure, the electrical
density of the irradiated volume would increase and therefore the
cross section of Compton scattering and probability of producing
secondary electrons or free radicals which have significant effect
on DEF would increase.1
The results of this study are consistent with previous studies and
the slight differences might be the effect of size and concentration
of nanoparticles.22–23
5. Conclusion
The results of this study showed that ZnO NPs could be used
as dose enhancing substances for megavoltage irradiation condi-
tion. Experimental measurements and simulation data showed that
dose enhancement increased by increasing concentration of NPs
and, therefore, the therapeutic ratio would grow. Many reasons
such as photoelectric, pair production effects and even Compton
scattering can cause DEF. Although MCNP5 simulation code canthe weak potential of MCNP5 in tracing the Auger electrons cause






cells in clinically relevant megavoltage radiation energies in-vitro. Nanomed J.
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